PRIMARY BILIARY CIRRHOSIS
Clinical trials for PRIMARY BILIARY CIRRHOSIS explained in plain language.
Never miss a new study
Get alerted when new PRIMARY BILIARY CIRRHOSIS trials appear
Sign up with your email to follow new studies for PRIMARY BILIARY CIRRHOSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for PBC patients: long-term drug safety trial underway
Disease control OngoingThis study tests the long-term safety of a drug called seladelpar in people with primary biliary cholangitis (PBC), a chronic liver disease. About 340 adults who have already taken seladelpar in a previous study will continue taking it for up to several years. Researchers will mo…
Matched conditions: PRIMARY BILIARY CIRRHOSIS
Phase: PHASE3 • Sponsor: Gilead Sciences • Aim: Disease control
Last updated May 26, 2026 04:37 UTC
-
New hope for rare liver disease: drug shows promise in Late-Stage trial
Disease control OngoingThis study tests a new drug called elafibranor for people with primary biliary cholangitis (PBC), a rare liver disease that can lead to scarring and liver failure. The trial includes 161 adults who did not get better with or could not take the standard medicine. The goal is to se…
Matched conditions: PRIMARY BILIARY CIRRHOSIS
Phase: PHASE3 • Sponsor: Ipsen • Aim: Disease control
Last updated May 13, 2026 15:59 UTC